Introduction. Breast cancer (BC) is the most commonly diagnosed cancer and a leading cause of death among women in the UK and worldwide.1 Annually, around 55 000 women are diagnosed with BC and 11 500 ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

A Caltech-led team has developed a safe, effective, and painless breast imaging technique that incorporates machine learning ...

A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...

When she brought up cryoablation to her medical oncologist at the University of Alabama at Birmingham O’Neal Comprehensive ...

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

Research presented at the ASCO Annual Meeting 2025 highlighted new potential standards of care and other advances in breast cancer.

What exactly is the “Price Tag” singer in for? A specialist spoke to The Post about what patient can expect when they’re diagnosed with stage 0 or stage 1 breast cancer.